Responses
Clinical pharmacy and clinical trials (including case series)
CPC-105 Pharmacoeconomic Aspects of the Treatment of Rheumatoid Arthritis with Tumour Necrosis Factor Alpha Antagonists: A Societal Perspective
Compose a Response to This Article
Other responses
No responses have been published for this article.